EHA Library - The official digital education library of European Hematology Association (EHA)

COMBINED PATTERNS OF IGHV REPERTOIRE AND MOLECULAR ALTERATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA- SINGLE CENTER EXPERIENCE
Author(s): ,
Sanja Trajkova
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Lidija Cevreska
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Aleksandar Dimovski
Affiliations:
Faculty of Pharmacy, University “Ss. Cyril and Methodius”,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Martin Ivanovski
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Marija Popova-Labacevska
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Dushko Dukovski
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
,
Bozidar Kocoski
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
Irina Panovska-Stavridis
Affiliations:
Hematology,University clinic for Hematology,Skopje,Macedonia, The Former Yugoslav Republic Of
(Abstract release date: 05/18/17) EHA Library. Trajkova S. 05/18/17; 182509; PB1795
S.T. Trajkova
S.T. Trajkova
Contributions
Abstract

Abstract: PB1795

Type: Publication Only

Background
The specific determining factors for malignant progression in Chronic lymphocytic leukemia (CLL ), remaining unknown.

Aims
To investigat the potential existence of unique cytogenetic profiles associated with specific IGHV repertoires that could be associated with an increased risk of progression in CLL.

Methods
For this purpose, molecular analysis of well-established cytogenetic alterations of chromosomes 11, 12, 13, 14 and 17 together with the pattern of rearrangement of the IGHV genes were performed in 100 CLL cases.

Results
Our results based on molecular analysis from 100 subjects living in the same geographical area, show the presence of three major groups of clones with distinct but partially overlying configurations of IGHV gene usage, IGHV mutational status and cytogenetic alterations. These included a group which mainly consisted of clinical advanced stage CLL with a skewed but different CLL-associated IGHV gene repertoire

( VH1-69 associated with HD3 gene and HJ6 gene), frequently associated with complex karyotypes and poor-prognosis cytogenetic alterations, a second group enhanced in clones expressing specific IGHV subgroups ( VH3-23 associated with HD2 genes and HJ6 gene) with no or isolated good-prognosis cytogenetic alterations and a third group of clones with intermediate features, with prevalence of mutated IGHV genes, and higher numbers of del(13q)+ clonal B-cells.

Conclusion
These findings suggest that the specific IGHV repertoire and IGHV mutational status of CLL B-cell clones may adjust the type of cytogenetic alterations acquired and their clinical significances. Further long-term follow-up studies investigating the IGHV gene repertoire of CLL clones in distinct geographic areas and microenvironments are required to validate our findings and discard or confirm the potential role of some antigen-binding BCR specificities contributing to clonal evolution.

Session topic: 6. Chronic lymphocytic leukemia and related disorders - Clinical

Keyword(s): prognosis, Mutation status, Genetic, B cell chronic lymphocytic leukemia

Abstract: PB1795

Type: Publication Only

Background
The specific determining factors for malignant progression in Chronic lymphocytic leukemia (CLL ), remaining unknown.

Aims
To investigat the potential existence of unique cytogenetic profiles associated with specific IGHV repertoires that could be associated with an increased risk of progression in CLL.

Methods
For this purpose, molecular analysis of well-established cytogenetic alterations of chromosomes 11, 12, 13, 14 and 17 together with the pattern of rearrangement of the IGHV genes were performed in 100 CLL cases.

Results
Our results based on molecular analysis from 100 subjects living in the same geographical area, show the presence of three major groups of clones with distinct but partially overlying configurations of IGHV gene usage, IGHV mutational status and cytogenetic alterations. These included a group which mainly consisted of clinical advanced stage CLL with a skewed but different CLL-associated IGHV gene repertoire

( VH1-69 associated with HD3 gene and HJ6 gene), frequently associated with complex karyotypes and poor-prognosis cytogenetic alterations, a second group enhanced in clones expressing specific IGHV subgroups ( VH3-23 associated with HD2 genes and HJ6 gene) with no or isolated good-prognosis cytogenetic alterations and a third group of clones with intermediate features, with prevalence of mutated IGHV genes, and higher numbers of del(13q)+ clonal B-cells.

Conclusion
These findings suggest that the specific IGHV repertoire and IGHV mutational status of CLL B-cell clones may adjust the type of cytogenetic alterations acquired and their clinical significances. Further long-term follow-up studies investigating the IGHV gene repertoire of CLL clones in distinct geographic areas and microenvironments are required to validate our findings and discard or confirm the potential role of some antigen-binding BCR specificities contributing to clonal evolution.

Session topic: 6. Chronic lymphocytic leukemia and related disorders - Clinical

Keyword(s): prognosis, Mutation status, Genetic, B cell chronic lymphocytic leukemia

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies